{"id":"W2110652219","doi":"10.1093/jn/137.6.1518s","title":"c-Abl Tyrosine Kinase and Inhibition by the Cancer Drug Imatinib (Gleevec/STI-571)","year":2007,"lang":"en","type":"article","venue":"Journal of Nutrition","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"","keywords":"Proto-oncogene tyrosine-protein kinase Src; SH3 domain; ABL; Tyrosine kinase; SH2 domain; Chronic myelogenous leukemia; Imatinib; Protein kinase domain; Chemistry; Imatinib mesylate; Cancer research; Kinase; Biochemistry; Cell biology; Biology; Signal transduction; Leukemia; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005296089,0.000114211,0.0002206753,0.0001014018,0.00008754594,0.00002378767,0.00004031748,0.00006204231,0.00009893523],"category_scores_gemma":[0.00007598233,0.00007543786,0.00007658406,0.000150802,0.00006592326,0.0001741943,0.00001458319,0.0002681967,0.000004707252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000659705,"about_ca_system_score_gemma":0.00009787014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009650942,"about_ca_topic_score_gemma":0.00002250673,"domain_scores_codex":[0.9989279,0.00003522808,0.0004202357,0.0001073938,0.0003337244,0.0001755532],"domain_scores_gemma":[0.9991355,0.0001131601,0.0003111556,0.0001129592,0.0001974429,0.0001297819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002820249,0.003407792,0.01334856,0.00081091,0.0003740919,0.0008690202,0.001248595,0.000006814012,0.5483896,0.0001796624,0.343125,0.08541971],"study_design_scores_gemma":[0.06669275,0.002513818,0.1400065,0.007511585,0.001584792,0.007881442,0.001847483,0.0003354019,0.6789604,0.002499293,0.08958837,0.0005780805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818889,0.009871211,0.0003263987,0.007135658,0.0001960874,0.000284578,0.00002143328,0.00001152188,0.0002641476],"genre_scores_gemma":[0.9945929,0.002411562,0.001332088,0.0006230631,0.000733635,0.000008966197,0.00002521338,0.0000164559,0.0002561282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2535367,"threshold_uncertainty_score":0.3076266,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01263089966122528,"score_gpt":0.2880250333575215,"score_spread":0.2753941336962962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}